Financhill
Back

Sarepta Therapeutics Quote, Financials, Valuation and Earnings

Sarepta Therapeutics Price Quote

$147.77
+1.42 (+0.97%)
(Updated: July 23, 2024 at 11:00 AM ET)

Sarepta Therapeutics Key Stats

Sell
48
Sarepta Therapeutics (SRPT) is a Sell

Day range:
$144.34 - $147.33
52-week range:
$55.25 - $173.25
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
9.92
P/B ratio:
14.39%

Volume:
1.1M
Avg. volume:
1.9M
1-year change:
38.24%
Market cap:
$13.8B
Revenue:
$1.2B
EPS:
$0.4

How Much Does Sarepta Therapeutics Make?

Is Sarepta Therapeutics Growing As A Company?

  • What Is Sarepta Therapeutics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.63%
  • What Is Sarepta Therapeutics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Sarepta Therapeutics Stock Price Performance

What Is Sarepta Therapeutics 52-Week High & Low?

Sarepta Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Sarepta Therapeutics?

Is Sarepta Therapeutics Cash Flow Positive?

  • What Is SRPT Cash Flow From Operations?
    Cash flow from operations (TTM) is -$533.7M
  • What Is Sarepta Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $45.3M
  • What Is Sarepta Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $40.5M

Sarepta Therapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    SRPT return on invested capital is 0.83%
  • What Is Sarepta Therapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is 0.54%
  • What Is SRPT Return On Equity?
    ROE is a measure of profitability and is 2.09%

Sarepta Therapeutics Earnings Date & Stock Price

Sarepta Therapeutics Competitors

Sarepta Therapeutics Dividend Yield

Data Unavailable

Sarepta Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 77.36%
Revenue: 63.1% 10.13%

Analyst Recommendations

Buy Recommendations: 9
Hold Recommendations: 4
Sell Recommendations: 0
Price Target: 198.28
Upside from Last Price: 35.48%

Major Shareholders

  • How many SRPT shares are owned by institutional investors?
    133.1M SRPT shares are owned by institutional investors
  • How many SRPT shares are owned by insiders?
    15.5M SRPT shares are owned by insiders